Expired activity

Please go to the PowerPak homepage and select a course.

Racial and Ethnic Disparities in Breast Cancer Management and Outcomes
How Can Care be Optimized for All?
(Webinar Archive)

Jointly provided by Postgraduate Healthcare Education (PHE) and Postgraduate Institute for Medicine (PIM).

This activity is supported by an independent educational grant from Gilead Sciences, Inc.

FACULTY

Veronica B. Ajewole, PharmD, BCOP
Associate Professor
Department of Pharmacy Practice, College of Pharmacy & Health Sciences
Texas Southern University
Adjunct Assistant Professor of Oncology
Houston Methodist Academic Institute
Houston Methodist Hospital
Houston, TX

Mandi L. Pratt-Chapman, PhD
Associate Professor
Department of Medicine
The George Washington University, School of Medicine and Health Sciences
Washington, DC

FINANCIAL DISCLOSURE

Drs. Ajewole and Pratt-Chapman have disclosed that they have no actual or potential conflict of interest in relation to this program.

The clinical reviewer, Lisa Hutchison, PharmD, has no actual or potential conflict of interest in relation to this program.

Susanne Batesko, RN, BSN, Robin Soboti, RPh, and Susan R. Grady, MSN, RN, as well as the planners, managers, and other individuals, not previously disclosed, who are in a position to control the content of Postgraduate Healthcare Education (PHE) continuing education (CE) activities hereby state that they have no relevant conflicts of interest and no financial relationships or relationships to products or devices during the past 12 months to disclose in relation to this activity. PHE is committed to providing participants with a quality learning experience and to improve clinical outcomes without promoting the financial interests of a proprietary business.

The PIM planners and managers have nothing to disclose.

ACCREDITATION STATEMENTS

PHARMACY
Postgraduate Healthcare Education, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

UAN: 0430-9999-22-064-H01-P
Credits: 1.0 hours (0.1 ceu)

Joint Accredidation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Postgraduate Healthcare Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours. Designated for 0.25 contact hours of pharmacotherapy credit for Advanced Practice Registered Nurses.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Published: October 11, 2022
Expires: October 11, 2023
Type of Activity: Application
Media: Internet
Fee Information: There is no fee. This is a free continuing education activity.
Estimated time to complete activity: 60 minutes

TARGET AUDIENCE

This accredited activity has been designed for oncology pharmacists, oncology nurses and nurse practitioners.

How to Earn Credit (Pharmacists)

During the period October 11, 2022 to October 11, 2023, participants must 1) read the learning objectives and faculty disclosures; 2) view the educational activity; and 3) complete the posttest and evaluation form directly after the activity within a maximum of 60 days of participating in the activity. To answer the questions, click on your selected choice for each answer then proceed to the next question. Once completed, click on the Grade Exam button at the bottom of the page. Your posttest will automatically be graded. If you successfully complete the posttest (score of 70% or higher), your statement of participation will be made available immediately. Click on the View Statement of Participation link and print the statement for your records. If you receive a score lower than 70%, you will receive a message notifying you that you did not pass the posttest. You will have 2 opportunities to pass the posttest. To receive Credit, you must provide your date of birth and NABP number. All Credit information will be uploaded into CPE monitor within 30 days.

Goal

The goal of this activity is to enhance the ability of oncology pharmacists, oncology nurses and NPs who manage and or interact with breast cancer patients to provide information, insights, and solutions, applicable at both systems and local levels to identify, address, and rectify inequities in oncology healthcare delivery.

EDUCATIONAL OBJECTIVES

Upon completion of this program, participants should be better able to:

• Analyze current evidence for biologic and genetic factors that influence breast cancer prevalence and outcomes, including triple-negative breast cancer
• Identify how screening and treatment guidelines for breast cancer, including triple-negative breast cancer, can be individualized to address the needs of patient groups, with the understanding that medical care is not "once size fits all"
• Apply improved breast cancer care practices by identifying and addressing multiple factors that affect those patient groups affected by inequalities and poor healthcare access

REQUIRED COMPUTER HARDWARE/SOFTWARE

Please ensure the computer system you plan to use meets the following minimum requirements:

• Operating System: Windows 98 or higher & Macintosh 2.2 or higher
• Internet Browser (Mac & Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher, & Opera 5 or higher
• Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
• Peripherals: Computer speakers or headphones
• Monitor Screen Resolution: 320 x 480 or higher
• Media Viewing Requirements: Adobe Reader, Microsoft PowerPoint, Flash Player & HTML5

Disclosure of Unlabeled Use and Disclaimer

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Postgraduate Healthcare Education, LLC, Postgraduate Institute for Medicine, or Gilead Sciences, Inc. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions, and possible contraindications on dangers in use, (review of any applicable manufacturer's product information) and comparison with recommendations of other authorities.

The author, sponsor, and publisher of this continuing education activity have made all reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific knowledge at the time of acceptance for publication. However, because information regarding drugs (their administration, dosages, contraindications, adverse reactions, interactions, special warnings, precautions, etc.) is subject to constant change, the reader is advised to check the manufacturer's package insert for information concerning recommended dosages and potential problems and cautions prior to dispensing or administering the drug. Special precautions should be taken when a drug is new, or highly toxic, or is unfamiliar to the dispenser or administrant. This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration (FDA). Neither the publisher nor sponsor promotes the use of any agent outside of approved labeling. Statements made in this activity have not been evaluated by the FDA.